We conduct due diligence reviews for Food and Drug Administration (FDA)-regulated companies engaging in mergers, acquisitions, licensing deals, and other corporate transactions. Our team is able to readily identify and evaluate the significance of FDA regulatory issues that may affect the value of a proposed transaction. Our firm knowledge of all junctures of FDA regulation enables us to incorporate regulatory diligence findings thoroughly into deal negotiations and terms. We also work closely with our corporate partners to identify other corporate issues that may have bearing on the overall negotiations.

Contact Us

Ann M. Begley
202.719.4585 | abegley@wiley.law

View all practice area professionals >

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.